Kezar Life Sciences, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2016 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Kezar Life Sciences, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
  • Kezar Life Sciences, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $3.19M, a 52% decline year-over-year.
  • Kezar Life Sciences, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $12.9M, a 31% decline year-over-year.
  • Kezar Life Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $18.1M, a 29.5% increase from 2022.
  • Kezar Life Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $14M, a 84.4% increase from 2021.
  • Kezar Life Sciences, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.6M, a 53.7% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $18.1M +$4.13M +29.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $14M +$6.41M +84.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $7.6M +$2.65M +53.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2020 $4.94M +$936K +23.4% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-14
2019 $4.01M +$2.01M +101% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 $1.99M +$1.79M +882% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-11
2017 $203K +$75K +58.6% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-12
2016 $128K Jan 1, 2016 Dec 31, 2016 10-K 2019-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.